Home LiteratureArticle Details
PMID: 19085040 Published · ppublish English Journal Article Review

Chemokine/chemokine receptor-mediated inflammation regulates pathologic changes from acute kidney injury to chronic kidney disease.

Clinical and experimental nephrology ·Vol. 13 ·No. 1 ·2009-02-00 ·Pages 9-14

Furuichi K, Kaneko S, Wada T

Abstract

Ischemia-reperfusion injury is a main cause of acute kidney injury. Tubular necrosis and interstitial inflammatory cell infiltration are characteristic pathologic changes of acute kidney injury. The main necrotic area should be repaired with new tubular epithelial cells after the injury. On the other hand, some parts of the injured kidney progress to interstitial fibrosis, a characteristic pathologic change in chronic kidney disease. We hypothesized that interstitial infiltrating leukocytes, that are attracted and activated by chemokines, are key mediators in the pathogenesis of tubular necrosis, regeneration of the necrotic area, or interstitial fibrosis. A large number of chemokines were upregulated after ischemic injury, and chemokine receptor-expressing inflammatory cells were attracted by these chemokines. Genetic or molecular modulating experiments in the mouse model have begun to reveal the key participants and their specific roles at the levels of inflammation, regeneration, and fibrosis. Among these chemokines/chemokine receptors, our data indicated CCR2-mediated macrophage infiltration mainly affected tubular necrosis after ischemic acute kidney injury, interferon-gamma-inducible protein (IP)-10-producing macrophages participate in regeneration of tubular epithelial cells, and CX3CR1-mediated macrophages and platelet infiltration and aggregation play roles in interstitial fibrosis in chronic kidney disease. These chemokines and chemokine receptors on infiltrating inflammatory cells would be novel clinical markers or targets for therapeutic intervention.

MeSH Terms
Acute Disease Animals Anti-Inflammatory Agents/therapeutic use Chemokines/metabolism Chronic Disease Disease Progression Fibrosis Humans Inflammation/drug therapy,immunology,pathology,physiopathology Kidney/drug effects,immunology,pathology,physiopathology Kidney Diseases/drug therapy,immunology,pathology,physiopathology Leukocytes/immunology Macrophages/immunology Necrosis Receptors, Chemokine/metabolism Regeneration Reperfusion Injury/drug therapy,immunology,pathology,physiopathology
Chemicals
Anti-Inflammatory Agents Chemokines Receptors, Chemokine
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Furuichi Kengo
Division of Blood Purification, Kanazawa University Hospital, 13-1 Takara-machi, Kanazawa, Japan. [email protected]
Kaneko Shuichi
Wada Takashi
References (51)
51 references, click to expand
  1. Hypoxia-inducible factor 1alpha (HIF-1alpha) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes.
    J Biol Chem. 1997 Sep 5;272(36):22642-7 PMID: 9278421
  2. Mechanisms of renal cell repair and regeneration after acute renal failure.
    J Pharmacol Exp Ther. 2003 Mar;304(3):905-12 PMID: 12604664
  3. In vivo transfection of NF-kappaB decoy oligodeoxynucleotides attenuate renal ischemia/reperfusion injury in rats.
    Kidney Int. 2004 Mar;65(3):834-45 PMID: 14871403
  4. Transforming growth factor beta in tissue fibrosis.
    N Engl J Med. 1994 Nov 10;331(19):1286-92 PMID: 7935686
  5. NF-kappa B: a pleiotropic mediator of inducible and tissue-specific gene control.
    Cell. 1989 Jul 28;58(2):227-9 PMID: 2665943
  6. Hypoxia and hypoxia-inducible factor in renal disease.
    Nephron Exp Nephrol. 2008;110(1):e1-7 PMID: 18667839
  7. Administration of FR167653, a new anti-inflammatory compound, prevents renal ischaemia/reperfusion injury in mice.
    Nephrol Dial Transplant. 2002 Mar;17(3):399-407 PMID: 11865084
  8. Accumulation of microglial cells expressing ELR motif-positive CXC chemokines and their receptor CXCR2 in monkey hippocampus after ischemia-reperfusion.
    Brain Res. 2003 Apr 25;970(1-2):195-204 PMID: 12706261
  9. C3a is required for the production of CXC chemokines by tubular epithelial cells after renal ishemia/reperfusion.
    J Immunol. 2007 Feb 1;178(3):1819-28 PMID: 17237432
  10. Gene therapy expressing amino-terminal truncated monocyte chemoattractant protein-1 prevents renal ischemia-reperfusion injury.
    J Am Soc Nephrol. 2003 Apr;14(4):1066-71 PMID: 12660342
  11. CXCR2/CXCR2 ligand biology during lung transplant ischemia-reperfusion injury.
    J Immunol. 2005 Nov 15;175(10):6931-9 PMID: 16272353
  12. Chemokine receptors: multifaceted therapeutic targets.
    Nat Rev Immunol. 2002 Feb;2(2):106-15 PMID: 11910892
  13. Chemokines, chemokine receptors, and renal disease: from basic science to pathophysiologic and therapeutic studies.
    J Am Soc Nephrol. 2000 Jan;11(1):152-176 PMID: 10616852
  14. Renal ischemia-reperfusion injury and adenosine 2A receptor-mediated tissue protection: role of macrophages.
    Am J Physiol Renal Physiol. 2005 Apr;288(4):F722-31 PMID: 15561971
  15. Activation of hypoxia-inducible transcription factor depends primarily upon redox-sensitive stabilization of its alpha subunit.
    J Biol Chem. 1996 Dec 13;271(50):32253-9 PMID: 8943284
  16. Midkine antisense oligodeoxyribonucleotide inhibits renal damage induced by ischemic reperfusion.
    Kidney Int. 2005 Apr;67(4):1330-9 PMID: 15780085
  17. IFN-inducible protein 10 (CXCL10) regulates tubular cell proliferation in renal ischemia-reperfusion injury.
    Nephron Exp Nephrol. 2008;109(1):c29-38 PMID: 18520167
  18. Tumor necrosis factor alpha and interferon gamma synergistically induce interleukin 8 production in a human gastric cancer cell line through acting concurrently on AP-1 and NF-kB-like binding sites of the interleukin 8 gene.
    J Biol Chem. 1992 Nov 5;267(31):22506-11 PMID: 1331059
  19. Inhibition of the chemokine receptor CXCR2 prevents kidney graft function deterioration due to ischemia/reperfusion.
    Kidney Int. 2005 May;67(5):1753-61 PMID: 15840022
  20. Molecular mechanisms of recovery from acute renal failure.
    Crit Care Med. 2003 Aug;31(8 Suppl):S572-81 PMID: 12907887
  21. CCR2 signaling contributes to ischemia-reperfusion injury in kidney.
    J Am Soc Nephrol. 2003 Oct;14(10):2503-15 PMID: 14514728
  22. Keratinocyte-derived chemokine is an early biomarker of ischemic acute kidney injury.
    Am J Physiol Renal Physiol. 2006 May;290(5):F1187-93 PMID: 16368740
  23. Cytokines and hormones in the regulation of hypoxia inducible factor-1alpha (HIF-1alpha).
    Cardiovasc Hematol Agents Med Chem. 2006 Jul;4(3):189-97 PMID: 16842205
  24. Chemokines in myocardial ischemia.
    Trends Cardiovasc Med. 2005 Jul;15(5):163-9 PMID: 16165012
  25. Opposing effects mediated by the chemokine receptor CXCR2 on myocardial ischemia-reperfusion injury: recruitment of potentially damaging neutrophils and direct myocardial protection.
    Circulation. 2003 Nov 11;108(19):2387-92 PMID: 14568904
  26. Chemokine receptor CX3CR1 regulates renal interstitial fibrosis after ischemia-reperfusion injury.
    Am J Pathol. 2006 Aug;169(2):372-87 PMID: 16877340
  27. Apoptosis and chemokine induction after renal ischemia-reperfusion.
    Transplantation. 2001 Apr 15;71(7):1007-11 PMID: 11349710
  28. Midkine is involved in neutrophil infiltration into the tubulointerstitium in ischemic renal injury.
    J Immunol. 2001 Sep 15;167(6):3463-9 PMID: 11544339
  29. Intervention of crescentic glomerulonephritis by antibodies to monocyte chemotactic and activating factor (MCAF/MCP-1).
    FASEB J. 1996 Oct;10(12):1418-25 PMID: 8903512
  30. Regeneration processes in the kidney after acute injury: role of infiltrating cells.
    Exp Nephrol. 1998 Nov-Dec;6(6):502-7 PMID: 9807021
  31. CD44: structure, function, and association with the malignant process.
    Adv Cancer Res. 1997;71:241-319 PMID: 9111868
  32. Prevention of proteinuria by the administration of anti-interleukin 8 antibody in experimental acute immune complex-induced glomerulonephritis.
    J Exp Med. 1994 Sep 1;180(3):1135-40 PMID: 8064229
  33. Neutralization of Gro alpha and macrophage inflammatory protein-2 attenuates renal ischemia/reperfusion injury.
    Am J Pathol. 2001 Dec;159(6):2137-45 PMID: 11733364
  34. Chemokines in ischemia and reperfusion.
    Thromb Haemost. 2007 May;97(5):738-47 PMID: 17479184
  35. The chemokine/chemokine-receptor family: potential and progress for therapeutic intervention.
    Curr Opin Chem Biol. 2000 Aug;4(4):420-7 PMID: 10959770
  36. Fibrocytes: a new insight into kidney fibrosis.
    Kidney Int. 2007 Aug;72(3):269-73 PMID: 17495856
  37. Expression of CD44 in kidney after acute ischemic injury in rats.
    Am J Physiol Regul Integr Comp Physiol. 2000 Jan;278(1):R247-54 PMID: 10644646
  38. Hydrogen peroxide induces tumor necrosis factor alpha-mediated cardiac injury by a P38 mitogen-activated protein kinase-dependent mechanism.
    Surgery. 1998 Aug;124(2):291-6; discussion 297 PMID: 9706151
  39. Chemokines and their receptors in the brain: pathophysiological roles in ischemic brain injury.
    Life Sci. 2003 Dec 5;74(2-3):321-7 PMID: 14607260
  40. Blockade of CCR2 ameliorates progressive fibrosis in kidney.
    Am J Pathol. 2004 Jul;165(1):237-46 PMID: 15215179
  41. Hypoxia and interleukin-1beta stimulate vascular endothelial growth factor production in human proximal tubular cells.
    Kidney Int. 2000 Jul;58(1):43-50 PMID: 10886548
  42. Met-RANTES reduces vascular and tubular damage during acute renal transplant rejection: blocking monocyte arrest and recruitment.
    FASEB J. 1999 Aug;13(11):1371-83 PMID: 10428761
  43. Contribution of stem cells to kidney repair.
    Am J Nephrol. 2008;28(5):813-22 PMID: 18535367
  44. Proteinuria and growth factors in the development of tubulointerstitial injury and scarring in kidney disease.
    Curr Opin Nephrol Hypertens. 2005 Jan;14(1):43-52 PMID: 15586015
  45. Chemokines in renal diseases.
    Int Immunopharmacol. 2001 Apr;1(4):637-45 PMID: 11357876
  46. Identification of a novel regulatory region critical for expression of the RANTES chemokine in activated T lymphocytes.
    J Immunol. 1996 Aug 1;157(3):1139-48 PMID: 8757619
  47. Monocyte chemoattractant protein-1 expression correlates with monocyte infiltration in the post-ischemic kidney.
    Ren Fail. 2002 Nov;24(6):703-23 PMID: 12472194
  48. Enhanced MCP-1 expression during ischemia/reperfusion injury is mediated by oxidative stress and NF-kappaB.
    Kidney Int. 2002 Oct;62(4):1160-70 PMID: 12234286
  49. Neutrophil-independent mechanisms of caspase-1- and IL-18-mediated ischemic acute tubular necrosis in mice.
    J Clin Invest. 2002 Oct;110(8):1083-91 PMID: 12393844
  50. Macrophages contribute to the initiation of ischaemic acute renal failure in rats.
    Nephrol Dial Transplant. 2006 May;21(5):1231-9 PMID: 16410269
  51. The thrombospondin 1-TGF-beta axis in fibrotic renal disease.
    Nephrol Dial Transplant. 2003 Jul;18(7):1241-5 PMID: 12808154
Article Info
Journal
Clinical and experimental nephrology
Abbr.
Clin Exp Nephrol
ISSN
1342-1751
DOI
10.1007/s10157-008-0119-5
Email
[email protected]
Published
2009-02-00
Epub
2008-00-16
Pages
9-14
Language
English
Region
Japan
NLM ID
9709923
Subset
IM
External Links
PubMed source DOI: 10.1007/s10157-008-0119-5 View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2